Clinical trial
Long Term Use of HPN-100 in Urea Cycle Disorders
NCT01257737 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long Term Use of HPN-100 in Urea Cycle Disorders
- Lead sponsor
- Amgen
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- October 4, 2010
- Completion date
- February 16, 2017
- Enrollment
- 88 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.
urea cycle disorders